*Ophthalmology Department, San Raffaele University Hospital, Milan, Italy; and
†Hospital Metropolitano, Quito, Ecuador.
Reprint requests: Giuseppe Querques, MD, PhD, Department of Ophthalmology, University Vita-Salute San Raffaele, Via Olgettina 60, Milan, Italy; e-mail: [email protected]
Disclosures: E. Borrelli: Recipient—CenterVue (Italy); Zeiss (Dublin, USA). R. Sacconi: Recipient—Zeiss (Dublin, USA). Francesco Bandello: Recipient—Alcon (Fort Worth, Texas, USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan, Inc (Irvine, California, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Schering Pharma (Berlin, Germany), Bausch & Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La Roche (Basel, Switzerland), Novagali Pharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), ThromboGenics (Heverlee, Belgium), Zeiss (Dublin, USA). Giuseppe Querques: Recipient—Alimera Sciences (Alpharetta, Georgia, USA), Allergan, Inc (Irvine, California, USA), Amgen (Thousand Oaks, USA), Bayer Schering Pharma (Berlin, Germany), CenterVue (Italy); Heidelberg (Germany), KBH (Chengdu, China), LEH Pharma (London, UK), LumiThera (Poulsbo, USA), Novartis (Basel, Switzerland), Sandoz (Berlin, Germany), SIFI (Catania, Italy), Sooft-Fidea (Abano, Italy), and Zeiss (Dublin, USA). The remaining authors has no financial/conflicting interests to disclose.
